Product Information
ESCITALOPRAM 5 MG TABLET is a generic product labeled by Jubilant Cadista Pharmaceuticals Inc., priced at $0.0412 per EA under NDC 59746027910. Its NADAC has been published 81 times since May 15, 2024.
Strength
5 mg/1
Manufacturer
Jubilant Cadista Pharmaceuticals Inc.NDC
59746027910
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
11/19/2025
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA202280On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM 5 MG TABLET has been published 81 times since May 15, 2024, and over the history we have for it it has risen 4.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0412 per EA |
|---|---|
| All-time high | $0.0474 (Jul 16, 2025) |
| All-time low | $0.0328 (Nov 20, 2024) |
| 52-week high | $0.0474 |
| 52-week low | $0.0412 |
| Median price | $0.0451 |
| Average price | $0.0429 |
| Largest weekly change | -27.3% (Nov 20, 2024) |
| Weeks tracked | 81 |
| Tracking since | May 15, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM 5 MG TABLET, manufactured by Jubilant Cadista Pharmaceuticals Inc., is $0.0412 per EA (NDC 59746027910), effective Nov 26, 2025.
How has the price of ESCITALOPRAM 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM 5 MG TABLET has risen 4.7%. It has been tracked across 81 weekly CMS publications since May 15, 2024.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM 5 MG TABLET?
Since May 15, 2024, the NADAC for ESCITALOPRAM 5 MG TABLET has ranged from a low of $0.0328 (Nov 20, 2024) to a high of $0.0474 (Jul 16, 2025), with a median of $0.0451 per EA.
Are there cheaper alternatives to ESCITALOPRAM 5 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as ESCITALOPRAM 5 MG TABLET, but none are currently priced below it.
Who manufactures ESCITALOPRAM 5 MG TABLET?
ESCITALOPRAM 5 MG TABLET (NDC 59746027910) is labeled by Jubilant Cadista Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification